# 3-Dimensional Mapping System: The PULSTAR Study

Study · id `cardio:ct-nct05618340` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05618340](<https://clinicaltrials.gov/study/NCT05618340>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05618340

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 149 participants.

## Technical summary

Registry record NCT05618340. Allocation not applicable; no masking; primary purpose treatment. Start 2022-09-26 (actual); primary completion 2024-03-27 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 149 participants (enrolled count; ClinicalTrials.gov record NCT05618340, source copy `cardio:ctgov-nct05618340-2025-07-24`, retrieved 2026-10-26)
- Started: 2022-09-26 (actual) (ClinicalTrials.gov record NCT05618340, source copy `cardio:ctgov-nct05618340-2025-07-24`, retrieved 2026-10-26)
- Primary completion: 2024-03-27 (actual) (ClinicalTrials.gov record NCT05618340, source copy `cardio:ctgov-nct05618340-2025-07-24`, retrieved 2026-10-26)
- Completion: 2024-06-01 (actual) (ClinicalTrials.gov record NCT05618340, source copy `cardio:ctgov-nct05618340-2025-07-24`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT05618340, source copy `cardio:ctgov-nct05618340-2025-07-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05618340-2025-07-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: 3-Dimensional Mapping System: The PULSTAR Study
- Condition: Paroxysmal Atrial Fibrillation
- Intervention (Device): Pulsed electric field ablation device;Cardiac Pulsed Electric Field Ablation Catheter
- Lead sponsor: Shanghai Shangyang Medical Technology Co., Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)

## Provenance

Content hash: 23516052a975c29101597e41372b05044c635d784b2dfa32485850583dbd17cf
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
